Editorial: Novel immunological characteristics and immunotherapeutic targets in pancreatic cancer.
作者信息
Khan Husain Yar, Lou Yu, Sexton-Bonacci Rachel E
机构信息
Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, United States.
Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
出版信息
Front Immunol. 2024 Jun 3;15:1428740. doi: 10.3389/fimmu.2024.1428740. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Novel immunological characteristics and immunotherapeutic targets in pancreatic cancer.
Front Immunol. 2024 Jun 3;15:1428740. doi: 10.3389/fimmu.2024.1428740. eCollection 2024.
2
Dilemma and Challenge of Immunotherapy for Pancreatic Cancer.
Dig Dis Sci. 2021 Feb;66(2):359-368. doi: 10.1007/s10620-020-06183-9. Epub 2020 Mar 5.
3
Immunotherapy for pancreatic ductal adenocarcinoma.
J Surg Oncol. 2021 Mar;123(3):751-759. doi: 10.1002/jso.26312.
4
An Immunological Glance on Pancreatic Ductal Adenocarcinoma.
Int J Mol Sci. 2020 May 8;21(9):3345. doi: 10.3390/ijms21093345.
5
Immunotherapeutic strategies in pancreatic ductal adenocarcinoma (PDAC): current perspectives and future prospects.
Mol Biol Rep. 2020 Aug;47(8):6269-6280. doi: 10.1007/s11033-020-05648-4. Epub 2020 Jul 13.
6
Current and future immunotherapeutic approaches in pancreatic cancer treatment.
J Hematol Oncol. 2024 Jun 4;17(1):40. doi: 10.1186/s13045-024-01561-6.
7
Regulation and modulation of antitumor immunity in pancreatic cancer.
Nat Immunol. 2020 Oct;21(10):1152-1159. doi: 10.1038/s41590-020-0761-y. Epub 2020 Aug 17.
8
Understanding the immune landscape and tumor microenvironment of pancreatic cancer to improve immunotherapy.
Mol Carcinog. 2020 Jul;59(7):775-782. doi: 10.1002/mc.23179. Epub 2020 Mar 12.
9
Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy.
Signal Transduct Target Ther. 2021 Feb 20;6(1):72. doi: 10.1038/s41392-020-00449-4.
10
Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment.
Front Immunol. 2018 May 14;9:1044. doi: 10.3389/fimmu.2018.01044. eCollection 2018.
引用本文的文献
1
Immunotherapy in the Battle Against Bone Metastases: Mechanisms and Emerging Treatments.
Pharmaceuticals (Basel). 2024 Nov 26;17(12):1591. doi: 10.3390/ph17121591.
本文引用的文献
1
Liver metastasis of pancreatic cancer: the new choice at the crossroads.
Hepatobiliary Surg Nutr. 2023 Feb 28;12(1):88-91. doi: 10.21037/hbsn-22-489. Epub 2023 Jan 16.
2
The identification of liver metastasis- and prognosis-associated genes in pancreatic ductal adenocarcinoma.
BMC Cancer. 2022 Apr 27;22(1):463. doi: 10.1186/s12885-022-09577-2.
3
Cold Tumors: A Therapeutic Challenge for Immunotherapy.
Front Immunol. 2019 Feb 8;10:168. doi: 10.3389/fimmu.2019.00168. eCollection 2019.
4
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.
N Engl J Med. 2013 Oct 31;369(18):1691-703. doi: 10.1056/NEJMoa1304369. Epub 2013 Oct 16.
Zotero 插件